These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 272980

  • 1. Pulmonary toxicity recurring after a six week course of busulfan therapy and after subsequent therapy with uracil mustard.
    Hankins DG, Sanders S, MacDonald FM, Drage CW.
    Chest; 1978 Mar; 73(3):415-6. PubMed ID: 272980
    [Abstract] [Full Text] [Related]

  • 2. Chronic granulocytic leukaemia. Comparison of uracil mustard and busulphan.
    Herrmann RP, Dougan L, Holt JA, Jackson JM, Matthews ML, Nelson AJ, Stenhouse NS, Woodliff HJ.
    Med J Aust; 1972 Apr 15; 1(16):789-91. PubMed ID: 4503393
    [No Abstract] [Full Text] [Related]

  • 3. Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia.
    Kirschner RH, Esterly JR.
    Cancer; 1971 May 15; 27(5):1074-80. PubMed ID: 5281244
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Busulfan lung.
    Pearl M.
    Am J Dis Child; 1977 Jun 15; 131(6):650-2. PubMed ID: 266839
    [Abstract] [Full Text] [Related]

  • 6. [The busulfan lung].
    Pintos Fuentes RJ, Reissenweber N.
    Hoja Tisiol; 1970 Jun 15; 27(1):84-97. PubMed ID: 5291024
    [No Abstract] [Full Text] [Related]

  • 7. [Fatal pulmonary fibrosis, with cellular lesions of the lung and pancreas, attributed to busulfan].
    Batzenschlager A, Oberling F, Guerbaoui M, Vetter JM.
    Arch Anat Pathol (Paris); 1972 Sep 15; 20(3):291-4. PubMed ID: 4507846
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Pulmonary fibrosis after busulfan therapy].
    Jandl H, Franke A, Albrecht G.
    Z Gesamte Inn Med; 1975 Dec 15; 30(24):799-801. PubMed ID: 1062873
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Toxic manifestations of busulfan therapy.
    Burns WA, McFarland W, Matthews MJ.
    Med Ann Dist Columbia; 1971 Sep 15; 40(9):567-72. PubMed ID: 5315525
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A case of pulmonary alveolar proteinosis complicating chronic myelogenous leukemia. A peculiar pathologic aspect of busulfan lung?
    Aymard JP, Gyger M, Lavallee R, Legresley LP, Desy M.
    Cancer; 1984 Feb 15; 53(4):954-6. PubMed ID: 6581857
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Additive pulmonary toxicity with melphalan and busulfan therapy.
    Schallier D, Impens N, Warson F, Van Belle S, De Wasch G.
    Chest; 1983 Oct 15; 84(4):492-3. PubMed ID: 6578007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.